Corridor · Sourcing Intelligence
Akunudo screens manufacturers of Cetirizine 10mg for United Arab Emirates registration before you ever see them — certification, stability zone for the climate, and dossier format clear first; commercial fit second. Identities stay sealed until NDA, so you can source without tipping your hand.
No manufacturer in the corridor matches this exact spec for United Arab Emirates right now.
Submit a mandate and we'll match it the moment a qualified manufacturer enters the corridor — and alert you.
Not a directory to wade through — a brokered, anonymized corridor. We only fully win when your deal closes.
Market access · United Arab Emirates
The Emirates Drug Establishment (EDE) is now the UAE federal authority for product registration, marketing authorisation and pricing — created by Federal Decree-Law 38/2024 (in force Jan 2025), with MoHAP's 44 core drug services transferred to EDE in January 2026 (MoHAP retains only narcotics-related functions). Registration is via the EDE portal with a GCC-aligned CTD and a UAE-licensed importer of record; a reliance model leans on FDA/EU approvals with a fast-track for innovative/critical-care products. Prices are set by external reference pricing and EDE is actively repricing (a 2026 EDE decision cut 168 chronic-disease medicines by up to ~60%).
The Emirates Drug Establishment (EDE), the federal authority created by Federal Decree-Law 38/2024 (in force Jan 2025); MoHAP transferred its core drug-registration, pricing and licensing services to EDE in January 2026. Company + facility registration precede product registration for import and trading, via the EDE portal, with GCC-DR harmonised review plus national steps.
CTD (GCC-DR aligned).
Yes — a UAE-licensed agent / importer of record (the 'importer' captured in the UAE registry).
Yes — the UAE runs a reliance-based model leaning on recognized reference authorities (US FDA / EU), with fast-track registration for innovative or lifesaving/critical-care products (as quick as ~25 days for qualifying cases).
GMP compliance / inspection is required under EDE; recognized prior approvals are leveraged under the reliance model.
Orientation intelligence compiled from public regulator and analyst sources as of the dates shown — not legal or regulatory advice. Rules change; confirm specifics (fees, timelines, baskets, eligibility) with the authority before acting. (Authority: EDE — Emirates Drug Establishment (the UAE federal drug authority; took over registration & pricing from MoHAP); as of 2026-06.)